Subject: Re: Follow Up
From: "Eric Schwerin" <[email-masked]>
To: "Hagerman,Chris" <[email-masked]>
Cc: "Hunter Biden" <[email-masked]>
Date: Tue, 25 Oct 2016 19:40:56 -0400

Thanks so much, Chris.  

Eric D. Schwerin
Rosemont Seneca Advisors, LLC
1010 Wisconsin Ave., NW
Suite 705
Washington, DC 20007
(202) 333-1880
[email-masked] <x-msg://59/[email-masked]>
P Consider the environment before printing this email.

> On Oct 25, 2016, at 7:36 PM, Hagerman,Chris <[email-masked]> wrote:
> 
> Eric,
> 
> I'll be glad I help. I will call you tomorrow morning to get more information. 
> 
> Chris Hagerman
> Director, Patient Affairs
> UT MD Anderson Cancer Center
> [email-masked] <mailto:[email-masked]>
> (713) 745-4731
> 
> On Oct 25, 2016, at 5:48 PM, Eric Schwerin <[email-masked] <mailto:[email-masked]>> wrote:
> 
>> Chris-
>> 
>> I wanted to follow up on my email from yesterday and see if you would be able to help my Aunt find a doctor at MD Anderson that she could talk to to get a second opinion.  
>> 
>> She’s meeting with her doctors tomorrow morning in San Francisco so we’d ideally like to talk to someone soon thereafter.  
>> 
>> As a reminder from yesterday, she was diagnosed with stage four lung cancer last week and it has spread to the brain and the lymph nodes.  I believe her doctors at CPMC may be looking to put her on Keytruda if he condition warrants it.
>> 
>> Let me know your thoughts if you get a chance.
>> 
>> Thanks,
>> 
>> Eric
>> 
>> 
>> 
>> Eric D. Schwerin
>> Rosemont Seneca Advisors, LLC
>> 1010 Wisconsin Ave., NW
>> Suite 705
>> Washington, DC 20007
>> (202) 333-1880
>> [email-masked] <x-msg://59/[email-masked]>
>> P Consider the environment before printing this email.
>> 
> The information contained in this e-mail message may be privileged, confidential, and/or protected from disclosure. This e-mail message may contain protected health information (PHI); dissemination of PHI should comply with applicable federal and state laws. If you are not the intended recipient, or an authorized representative of the intended recipient, any further review, disclosure, use, dissemination, distribution, or copying of this message or any attachment (or the information contained therein) is strictly prohibited. If you think that you have received this e-mail message in error, please notify the sender by return e-mail and delete all references to it and its contents from your systems.
>